Madison Dearborn Partners To Acquire Majority Stake In Unison From Carlyle

RTTNews | 710天前
Madison Dearborn Partners To Acquire Majority Stake In Unison From Carlyle

(RTTNews) - Unison, a leading provider of procurement, supply chain, and contract management software to U.S. federal government agencies and government contractors, announced Tuesday that it will receive a strategic majority investment from funds affiliated with private equity investment firm Madison Dearborn Partners, LLC.

As part of the transaction, funds managed by global investment firm Carlyle Group (CG) will sell its majority stake to MDP, while remaining a strategic partner as a minority investor. MDP joins existing investors, Carlyle and Unison management, to provide additional resources and industry expertise to Unison. Financial terms were not disclosed.

The transaction is anticipated to close in the third quarter of 2022. Upon closing, funds associated with MDP will own a controlling stake in Unison, while Carlyle will retain a significant minority equity position.

Unison's management team will continue to serve in their current roles and members of Unison leadership will maintain a significant portion of their investment in Unison.

read more
Canadian Stocks Turning In Mixed Performance; TSX Down Marginally

Canadian Stocks Turning In Mixed Performance; TSX Down Marginally

The Canadian market is down in negative territory on Friday with stocks turning in a mixed performance as investors digest the latest batch of economic data from Canada and the U.S., and assessing the likely interest rate moves by the Federal Reserve.
RTTNews | 5小時14分鐘前
U.S. Dollar Advances Following Strong PMI Data

U.S. Dollar Advances Following Strong PMI Data

The U.S. dollar was higher against its major counterparts in the New York session on Friday, as the nation's private sector activity accelerated in June, marking the highest level since April 2022.
RTTNews | 5小時15分鐘前
U.S. Leading Economic Index Falls More Than Expected In May

U.S. Leading Economic Index Falls More Than Expected In May

A report released by the Conference Board on Friday showed its reading on leading U.S. economic indicators fell by more than expected in the month of May. The Conference Board said its leading economic index decreased by 0.5 percent in May following a 0.6 percent decline in April. Economist had expected the index to dip by 0.3 percent.
RTTNews | 7小時0分鐘前
U.S. Existing Home Sales Decrease Roughly In Line With Estimates In May

U.S. Existing Home Sales Decrease Roughly In Line With Estimates In May

The National Association of Realtors released a report on Friday showing existing home sales in the U.S. decreased roughly in line with economist estimates in the month of May. The report said existing home sales slid 0.7 percent to an annual rate of 4.11 million in May after tumbling by 1.9 percent to an annual rate of 4.14 million.
RTTNews | 7小時3分鐘前
UK Private Sector Grows At Slowest Pace In 7 Months

UK Private Sector Grows At Slowest Pace In 7 Months

The UK private sector growth weakened to a seven-month low in June as the slowdown in the service sector growth offset the stronger performance in manufacturing, flash survey results published by S&P Global revealed on Friday. The flash composite output index dropped unexpectedly to 51.7 in June from 53.0 in May. The score was forecast to rise marginally to 53.1.
RTTNews | 8小時10分鐘前
UK Public Debt Highest Since 1960s; Budget Deficit Remains Below Estimate

UK Public Debt Highest Since 1960s; Budget Deficit Remains Below Estimate

The UK public sector net debt rose to its highest level since early 1960s, while public sector borrowing remained below the official estimate, the Office for National Statistics reported Friday. Public sector net debt excluding public sector banks was estimated at 99.8 percent of gross domestic product at the end of May. This was 3.7 percentage points more than at the end of May 2023.
RTTNews | 8小時51分鐘前
Iterum Therapeutics Says FDA Determines To Take NDA For Sulopenem To Advisory Committee

Iterum Therapeutics Says FDA Determines To Take NDA For Sulopenem To Advisory Committee

Pharmaceutical company Iterum Therapeutics plc (ITRM) announced Friday that the U.S. Food and Drug Administration (FDA) has determined that the New Drug Application (NDA) for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women will be taken to Advisory Committee.
RTTNews | 9小時5分鐘前